$599

Vertex to Acquire ViaCyte; Another Medtronic Pump Recall; Insulet-Roche Settle Patent Lawsuit; Ionis licenses IgAN Asset to Roche; California to Manufacture Its Own Low-cost Insulin?

A series of cardiometabolic-related news items have been observed from Vertex, Medtronic, Insulet, Roche, Ionis, and state of California. Below, FENIX provides highlights and insights for the respective new items.

This content is for Read Less members only.
Register
Already a member? Log in here